« Back to Team
Mohan joined Mersana in October 2021, bringing a deep expertise in overall asset strategy and program management to the Mersana team. Mohan has overseen the advancement of products through early, mid and late-stage clinical development and has helped launch 7 oncology products globally. Mohan Bala, Ph.D., was most recently Chief Operating Officer at Constellation Pharmaceuticals, where he was responsible for overall asset strategy and program management.
Prior to joining Constellation, Mohan served as VP, Development Program Lead at TESARO, where he led cross-functional teams to advance two products to Phase 2, and one product to regulatory filing. He has been involved in multiple successful BLA and MAAs, including the filing of a companion diagnostic. Earlier in his career, Mohan held senior leadership roles at Sanofi, GlaxoSmithKline and Centocor, where he gained deep experience and expertise in market access, health economics and launch planning.
Dr. Bala holds a Ph.D. in Management Science and an M.B.A from the University of Chicago and has co-authored over 50 peer reviewed articles published in medical and economics journals.